Plasma rich in growth factors as treatment for a full-thickness macular hole due to macular telangiectasia type 2.
Arch Soc Esp Oftalmol (Engl Ed)
; 97(4): 219-223, 2022 Apr.
Article
em En
| MEDLINE
| ID: mdl-35523468
ABSTRACT
Full-thickness macular hole is a rare complication of macular telangiectasia type 2, and its treatment is still controversial. A patient with a full-thickness macular hole secondary to macular telangiectasia type 2 underwent vitreoretinal surgery with a plasma rich in growth factors membrane in the macular hole. At the sixth month of follow-up, anatomical and functional improvements were achieved, with no adverse effects. Plasma rich in growth factors is a new option, with advantages due to its biological properties that achieves good results in terms of safety and effectiveness in the surgical treatment of macular hole.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Perfurações Retinianas
/
Telangiectasia Retiniana
Tipo de estudo:
Etiology_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article